A randomized controlled trial of propranolol for infantile hemangiomas.

@article{Hogeling2011ARC,
  title={A randomized controlled trial of propranolol for infantile hemangiomas.},
  author={Marcia Hogeling and Susan Adams and Orli Wargon},
  journal={Pediatrics},
  year={2011},
  volume={128 2},
  pages={e259-66}
}
OBJECTIVE Propranolol hydrochloride is a safe and effective medication for treating infantile hemangiomas (IHs), with decreases in IH volume, color, and elevation. METHODS Forty children between the ages of 9 weeks and 5 years with facial IHs or IHs in sites with the potential for disfigurement were randomly assigned to receive propranolol or placebo oral solution 2 mg/kg per day divided 3 times daily for 6 months. Baseline electrocardiogram, echocardiogram, and laboratory evaluations were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 14 times over the past 90 days. VIEW TWEETS
84 Citations
16 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 84 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 16 references

Hemangioma and propranolol . Some remarks at the end of treatment . Differences from corticosteroids

  • N Laforgia, A Milano, E DeLeo, E Bonifazi
  • Eur J Pediat Derma
  • 2009

Similar Papers

Loading similar papers…